Cite
HARVARD Citation
Li, J. et al. (2018). Compound F779-0434 causes synthetic lethality in BRCA2-deficient cancer cells by disrupting RAD52–ssDNA association. RSC advances. 8 (34), pp. 18859-18869. [Online].
This is an interim version of our Electronic Legal Deposit Catalogue-eJournals and eBooks while we continue to recover from a cyber-attack.
Li, J. et al. (2018). Compound F779-0434 causes synthetic lethality in BRCA2-deficient cancer cells by disrupting RAD52–ssDNA association. RSC advances. 8 (34), pp. 18859-18869. [Online].